{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:43:50Z","timestamp":1792273430538,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Financial toxicity (FT) refers to the direct and indirect consequences of cancer diagnosis and treatment and is a key mediator of quality of life (QOL) and survival in cancer patients. To address this, financial navigation (FN) programs have been implemented in many cancer centers. At our large tertiary care cancer center, the FN program uses the Comprehensive Score for Financial Toxicity (COST) to screen patients undergoing first cancer treatment. We aimed to better understand FT, risk factors, and association with outcomes in our cancer population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We identified 1906 patients with any cancer diagnosis and a completed COST between 6\/2021 and 2\/2024. Sociodemographic data including the Area Deprivation Index (ADI), disease, and treatment characteristics as well as patient-reported outcomes (PROMIS10, PHQ9 and NCCN DT) were collected. Risk factors for FT and association of FT on overall survival (OS) were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Median age was 65\u00a0years (IQR 56\u201372); 54% female, 82% white, 57% married, 47% insured privately, and 35% with Medicare. Younger age, race\/ethnicity, insurance type, tobacco use, and higher ADI were associated with higher FT. Higher distress (NCCN DT,\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20091001) and lower physical (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20091474) and mental (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20091505) health (PROMIS10) were also associated with higher FT. FT was not associated with time to treat (TTT) or OS. However, higher ADI was significantly associated with TTT (HR 0.98, 95% CI 0.96\u20131.00,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04) but not OS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study provides insights into risk factors for FT in a large cancer population. We did not demonstrate a significant association of FT on survival. Further analysis in specific disease groups is needed to better understand these relationships.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-11344-z","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:11:40Z","timestamp":1792231900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing financial toxicity with COST-FACIT: experience from a tertiary care cancer center"],"prefix":"10.1007","volume":"34","author":[{"given":"Mahir","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth N.","family":"Dewey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Strzalka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarushi","family":"Bhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather McKee","family":"Hurwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Stegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Hurn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Tomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1252-6539","authenticated-orcid":false,"given":"Betty K.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"11344_CR1","doi-asserted-by":"crossref","unstructured":"Lentz R, Benson AB 3rd, Kircher S (2019) Financial toxicity in cancer care: prevalence, causes, consequences, and reduction strategies. J Surg Oncol 120(1):85\u201392","DOI":"10.1002\/jso.25374"},{"key":"11344_CR2","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1158\/1055-9965.EPI-19-1534","volume":"29","author":"AB Mariotto","year":"2020","unstructured":"Mariotto AB, Enewold L, Zhao J et al (2020) Medical care costs associated with cancer survivorship in the United States. Cancer Epidemiol Biomarkers Prev 29:1304\u20131312","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"11344_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/jama.2009.187","volume":"301","author":"AG de Boer","year":"2009","unstructured":"de Boer AG, Taskila T, Ojajarvi A et al (2009) Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA 301:753\u2013762","journal-title":"JAMA"},{"key":"11344_CR4","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1002\/cncr.28214","volume":"119","author":"EC Dowling","year":"2013","unstructured":"Dowling EC, Chawla N, Forsythe LP et al (2013) Lost productivity and burden of illness in cancer survivors with and without other chronic conditions. Cancer 119:3393\u20133401","journal-title":"Cancer"},{"key":"11344_CR5","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1200\/JCO.2013.49.1241","volume":"31","author":"GP Guy Jr","year":"2013","unstructured":"Guy GP Jr, Ekwueme DU, Yabroff KR et al (2013) Economic burden of cancer survivorship among adults in the United States. J Clin Oncol 31:3749\u20133757","journal-title":"J Clin Oncol"},{"key":"11344_CR6","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1200\/JCO.2015.63.2232","volume":"34","author":"CS Lathan","year":"2016","unstructured":"Lathan CS, Cronin A, Tucker-Seeley R et al (2016) Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. J Clin Oncol 34:1732\u20131740","journal-title":"J Clin Oncol"},{"key":"11344_CR7","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1200\/JCO.2015.64.6620","volume":"34","author":"SD Ramsey","year":"2016","unstructured":"Ramsey SD, Bansal A, Fedorenko CR et al (2016) Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol 34:980\u2013986","journal-title":"J Clin Oncol"},{"key":"11344_CR8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2022.07.017","volume":"26","author":"S Pangestu","year":"2023","unstructured":"Pangestu S, Rencz F (2023) Comprehensive score for financial toxicity and health-related quality of life in patients with cancer and survivors: a systematic review and meta-analysis. Value Health 26:300\u2013316","journal-title":"Value Health"},{"key":"11344_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","volume":"18","author":"SY Zafar","year":"2013","unstructured":"Zafar SY, Peppercorn JM, Schrag D et al (2013) The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient\u2019s experience. Oncologist 18:381\u201390","journal-title":"Oncologist"},{"key":"11344_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1200\/JCO.2017.74.5091","volume":"36","author":"JA Doshi","year":"2018","unstructured":"Doshi JA, Li P, Huo H et al (2018) Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents. J Clin Oncol 36:476\u2013482","journal-title":"J Clin Oncol"},{"key":"11344_CR11","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1002\/cncr.28262","volume":"119","author":"EE Kent","year":"2013","unstructured":"Kent EE, Forsythe LP, Yabroff KR et al (2013) Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer 119:3710\u20133717","journal-title":"Cancer"},{"key":"11344_CR12","doi-asserted-by":"publisher","first-page":"60s","DOI":"10.1200\/JOP.2013.000971","volume":"9","author":"LL Zullig","year":"2013","unstructured":"Zullig LL, Peppercorn JM, Schrag D et al (2013) Financial distress, use of cost-coping strategies, and adherence to prescription medication among patients with cancer. J Oncol Pract 9:60s\u201363s","journal-title":"J Oncol Pract"},{"key":"11344_CR13","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/jnci\/djac044","volume":"114","author":"KR Yabroff","year":"2022","unstructured":"Yabroff KR, Han X, Song W et al (2022) Association of medical financial hardship and mortality among cancer survivors in the United States. J Natl Cancer Inst 114:863\u2013870","journal-title":"J Natl Cancer Inst"},{"key":"11344_CR14","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1007\/s00520-021-06084-1","volume":"29","author":"EC Dee","year":"2013","unstructured":"Dee EC, Nipp RD, Muralidhar V et al (2013) Financial worry and psychological distress among cancer survivors in the United States, 2013-2018. Support Care Cancer 29:5523\u20135535","journal-title":"Support Care Cancer"},{"key":"11344_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/cncr.29808","volume":"122","author":"HP Kale","year":"2016","unstructured":"Kale HP, Carroll NV (2016) Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer 122:283\u2013289","journal-title":"Cancer"},{"key":"11344_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00520-020-05468-z","volume":"29","author":"ES Ver Hoeve","year":"2021","unstructured":"Ver Hoeve ES, Ali-Akbarian L, Price SN et al (2021) Patient-reported financial toxicity, quality of life, and health behaviors in insured US cancer survivors. Support Care Cancer 29:349\u2013358","journal-title":"Support Care Cancer"},{"key":"11344_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.6004\/jnccn.2024.7030","volume":"22","author":"SB Wheeler","year":"2024","unstructured":"Wheeler SB, Manning ML, Gellin M et al (2024) Impact of a comprehensive financial navigation intervention to reduce cancer-related financial toxicity. J Natl Compr Canc Netw 22:557\u2013562","journal-title":"J Natl Compr Canc Netw"},{"key":"11344_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cncr.30369","volume":"123","author":"JA de Souza","year":"2017","unstructured":"de Souza JA, Yap BJ, Wroblewski K et al (2017) Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive score for financial Toxicity (COST). Cancer 123:476\u2013484","journal-title":"Cancer"},{"key":"11344_CR19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.6615","author":"JA De Souza","year":"2017","unstructured":"De Souza JA, Wroblewski K, Proussaloglou E et al (2017) Validation of a financial toxicity (FT) grading system. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2017.35.15_suppl.6615","journal-title":"J Clin Oncol"},{"key":"11344_CR20","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMp1802313","volume":"378","author":"AJH Kind","year":"2018","unstructured":"Kind AJH, Buckingham WR (2018) Making neighborhood-disadvantage metrics accessible - the Neighborhood Atlas. N Engl J Med 378:2456\u20132458","journal-title":"N Engl J Med"},{"key":"11344_CR21","unstructured":"University of Wisconsin School of Medicine and Public Health. 2013\u20132017 Area Deprivation Index v2.0. Downloaded from https:\/\/www.neighborhoodatlas.medicine.wisc.edu\/ Dec 14, 2025,"},{"key":"11344_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/0471722146","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2000","unstructured":"Hosmer DW, Lemeshow S (2000) Applied logistic regression. Wiley, New York"},{"key":"11344_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1200\/OP.24.00105","volume":"21","author":"S Kadambi","year":"2025","unstructured":"Kadambi S, Wang Y, Job A et al (2025) Financial toxicity in older adults with cancer and their caregivers. JCO Oncol Pract 21:92\u201399","journal-title":"JCO Oncol Pract"},{"key":"11344_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/pon.5763","volume":"31","author":"C Benedict","year":"2022","unstructured":"Benedict C, Fisher S, Schapira L et al (2022) Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors. Psychooncology 31:9\u201320","journal-title":"Psychooncology"},{"key":"11344_CR25","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1182\/blood-2024-207908","volume":"144","author":"N Syed","year":"2024","unstructured":"Syed N, Dusetzina S, Koyama T et al (2024) Insurance, financial strain, family function, and psychosocial wellbeing in pediatric patients and parents with hematologic malignancies. Blood 144:2279\u20132279","journal-title":"Blood"},{"key":"11344_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.6872","volume":"7","author":"ML Hsu","year":"2024","unstructured":"Hsu ML, Boulanger MC, Olson S et al (2024) Unmet needs, quality of life, and financial toxicity among survivors of lung cancer. JAMA Netw Open 7:e246872","journal-title":"JAMA Netw Open"},{"key":"11344_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.6004\/jnccn.2016.0010","volume":"14","author":"BJ Bolwell","year":"2016","unstructured":"Bolwell BJ, Khorana AA (2016) Enhancing value for patients with cancer: time to treatment as a surrogate for integrated cancer care. J Natl Compr Canc Netw 14:115\u20136","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11344-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11344-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11344-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:01:46Z","timestamp":1792270906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11344-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["11344"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11344-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Cleveland Clinic Institutional Review Board (IRB 23-1362) The requirement for informed consent was waived due to its retrospective design. This study was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1119"}}